Background--Up to half of patients undergoing percutaneous coronary intervention have multivessel coronary artery disease (MVD) with conflicting data regarding optimal revascularization strategy in such patients. This paper assesses the evidence for complete revascularization (CR) versus incomplete revascularization in patients undergoing percutaneous coronary intervention, and its prognostic impact using meta-analysis.
observational studies and post hoc analyses of randomized controlled trials. [4] [5] [6] [7] [8] The only prospective randomized controlled trial (RCT) outside the context of ST-elevation myocardial infarction (STEMI) comparing the safety, efficacy, and costs of complete versus "culprit" vessel revascularization in multivessel coronary artery disease treated with PCI showed no difference in major adverse cardiovascular event (MACE) rates between the 2 strategies, with a lower cost associated with the culprit-only strategy in the shorter term, although costs equalized in the longer term. 9 Recent data from randomized trials including the PRAMI, 10 CvLPRIT, 11 and DANAMI-3-PRIMULTI trials, 12 which recruited patients presenting with STEMI undergoing primary PCI, have shown that multivessel "complete" revascularization is associated with better outcomes than culprit-only revascularization. However, despite these data, important uncertainties still exist about the optimal strategy for such patients. Furthermore, in patients with stable coronary artery disease, international PCI guidelines do not provide guidance about the performance of complete revascularization (CR) versus IR, although functional assessment of lesions using noninvasive tests or fractional flow reserve (FFR) is recommended to avoid unnecessary treatment of nonsignificant stenosis [13] [14] [15] because this is associated with adverse outcomes. In a previous meta-analysis by Garcia et al 16 including 90 000 individuals with multivessel disease, incomplete revascularization in 25 938 CABG patients (29% from 16 studies) and 63 945 PCI patients (71% from 24 publications) was associated with increased risk of mortality, myocardial infarction, and repeat revascularization irrespective of the revascularization strategy employed. Since then many studies have been published including large registry data, 13, 17 post hoc analyses of randomized trials, 6, 18, 19 and observational studies 7, [20] [21] [22] [23] [24] to assess effectiveness of complete coronary revascularization. Our objectives were to assess and update the current evidence for complete revascularization and its prognostic impact in PCI by performing a meta-analysis of 38 studies including over 150 000 patients (excluding the STEMI and surgical revascularization cohorts).
Methods Eligibility Criteria
The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines were followed. 25 Studies were selected of patients who underwent PCI, reporting mortality or cardiovascular events among patients with and without complete revascularization with no restriction based on study design or the indication for PCI. Publications that did not report either mortality or MACE were excluded. 5 3 and 4 (292) . We excluded the STEMI and surgical revascularization cohorts. The definitions of "complete revascularization" are given in Table 1 . Studies in all languages were included. The bibliographies of the included studies and relevant review articles were checked for additional relevant articles.
Study Selection and Data Extraction
Two reviewers (V.N. and M.M.) independently checked all titles and abstracts for studies potentially meeting the inclusion criteria. The full reports of these studies were retrieved, and data were independently extracted on study design, participant characteristics, complete revascularization definition, outcome events, and follow-up.
Quality Assessment
The Newcastle-Ottawa Scale (NOS) 26 was used as an assessment tool for selection, comparability, and outcome assessment. Study quality was rated on a scale from 1 (very poor) to 9 (high). Publication bias was assessed using an Egger regression model 27 and the fail-safe number method. 28 
Data Analysis
The program Comprehensive Meta-analysis (version 2.0) was used to conduct DerSimonian and Laird random-effects metaanalysis. 29 Risk ratio (RR) and 95% confidence intervals (CI) were calculated. Adjusted or propensity-matched risk estimates were used when available. Meta-regression analysis was conducted to assess the relationship with continuous variables and outcomes. The Cochrane Q-statistic (I 2 ) was used to assess the consistency among studies, with I 2 <25% considered low, I 2 >50% moderate, and I 2 >75% high heterogeneity. 30 
Results

Study Population
A total of 425 publications were screened; then, 38 relevant studies* including 156 240 patients met our selection criteria ( Figure 1 ). We excluded previous meta-analysis 16, [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] and trials comparing target lesion revascularization versus upfront revascularization STEMI. [10] [11] [12] [67] [68] [69] [70] The studies included were mostly observational and included large registries 13, 17, 50, 53 or post hoc analyses of randomized trials such as the SYNTAX trial, 6 FAME trial, 18 ARTS trial, 31 ARTS-II Study, 44 MASS II trial, 36 BARI trial, 33 CABRI trial, 34 and the ACUITY trial. 8 Only 1 randomized single-center trial 9 has been published so far that compares the outcomes of complete and incomplete percutaneous revascularization. The publication dates ranged from 1988 to 2016, and the follow-up period for patients ranged between 1 and 11 years. The numbers of patients in each study were variable and ranged between 192 and 23 342 individuals. Most of these participants were male, and the percentage of females ranged from 7% to 37%; the mean age reported in the studies varied from 52 to 68 years. The percentage of ACS ranged from 0% to 100%.
Most of the studies used an anatomic definition for complete revascularization. Only 1 study used a functional definition (coronary lesions with fractional flow reserve ≤0.75 to 0.80 received a stent), 43 and 7 others utilized a scorebased assessment (SYNTAX score; a residual score of 0 is considered to be complete revascularization) for complete revascularization. 5, 6, 17, 19, [21] [22] [23] The percentage of complete revascularization ranged from 17% to 70% with a mean of 42.7%. The study characteristics have been tabulated in Table 2 . The results of the studies that evaluated incomplete revascularization and adverse outcomes are shown in Table 3 .
Outcomes: Overall and Subgroup Analysis Based on CR Definition and Chronic Total Occlusion Revascularization
There was a significantly lower risk of death with complete revascularization (Figure 2 
Regression Analysis Based on Proportion of CR
A regression analysis was conducted, and a negative relationship was observed between the mortality and the percentage of CR. From the regression model, there was very strong evidence that the OR of mortality was inversely related to CR with a P<0.001 (df=34). Log OR of mortality decreased by 1.25 (95% CI À1.64 to À0.88) for every 1% increase in CR. There was no relationship between the odds ratio of mortality and year of publication.
Heterogeneity and Publication Bias
There was significant heterogeneity noted among the different studies that could be explained by diverse population groups.
The degree of heterogeneity reduced to a minimal amount once subgroup analysis was performed based on a scorebased definition of complete revascularization, suggesting similar study designs and population cohorts. The results have been summarized in Table 4 . There was no publication bias identified using the Egger regression model.
Discussion
In our meta-analysis of 38 studies including over 156 240 patients undergoing PCI, we observed that fewer than half of all patients with multivessel coronary artery disease have CR. We observed that CR is associated with a lower rate of mortality, myocardial infarction, and MACE, irrespective of whether an anatomical or a score-based definition of IR was used, and that the magnitude of risk relates to degree of CR on metaregression. Our analysis builds on the work done by Garcia et al 16 by placing a focus on PCI and including new studies. Table 2 . Patients not meeting the definition of CR were defined as having IR divided into 4 subgroups:
(1) 1 IR vessel with no total occlusion; (2) 1 IR vessel with total occlusion; (3)
≥2
IR vessels with no total occlusion; and (4) 
Continued
There are several reasons why IR might not be achieved in PCI including patient clinical characteristics, lesion characteristics, failed PCI, and operator choice. Independent predictors of IR include advanced age, race, impaired LV function, previous MI, and comorbidities such as peripheral arterial disease, heart failure, diabetes, and renal failure. 38 The most common lesion/anatomical characteristics for not achieving CR with PCI in SYNTAX were the presence of CTO (OR 2.46, 95% CI 1.81-3.39; P<0.01), bifurcation disease (RR 1.44, 95% CI 1.09-1.89; P<0.01), and diffuse disease or small vessels (<2 mm) (RR 1.53, 95% CI 1.12-2.10, P<0.008).
72
Previous studies have shown that patients with IR have a greater prevalence of adverse clinical characteristics, are older, and have more complex lesions than patients with CR. 8, 35, 38, 39, 73 These adverse procedural characteristics might contribute to the associations reported. Most of the studies included in this analysis are derived from registry data; hence, the decision not to undertake CR by the operator may reflect uncaptured comorbid conditions/general frailty of the patient and so act as a surrogate of poor health status of the patients, which will contribute to the poorer outcomes reported. Although nearly all of the studies have adjusted for differences in baseline characteristics, the possibility of unmeasured confounding, particularly in studies derived from registry data, is significant. Furthermore, the increased risk associated with IR may relate to the complexity/extensiveness of coronary artery disease at baseline. For example, a post hoc analysis of the ARTS trial revealed that IR was associated with worse outcomes only in patients in the highest SYNTAX score tertile, whereas in the low and middle tertiles IR was not an independent predictor of adverse outcomes. Our meta-regression analysis suggests that outcomes relate to the degree of CR, in agreement with several previous studies. Indeed, post hoc analysis of the SYNTAX trial suggests higher degrees of IR, as measured by the SYNTAX revascularization index, were associated with increased 5-year cardiac death, AMI, and major adverse cardiac or cerebrovascular events (MACCE). 6 Similarly, Park et al 17 showed in the EXCELLENT registry that patient-orientated 
Limitations
There are several limitations associated with our analysis. First, although we report an association between IR and adverse clinical outcomes, we cannot infer a causal relationship. We have shown an association between IR and adverse outcomes, but it cannot be assumed that treating such patients with IR with additional PCI to attain CR would improve their prognosis. Second, for anatomical based definitions of IR, there are no universally accepted definitions of lesion "significance" with studies defining significant lesions as those with diameter stenosis (DS) varying between ≥50% and ≥70% in vessels of diameter ≥1.5 mm in some studies to ≥2.5 mm in other studies. Many of the studies included in this analysis used visual assessment to define lesion severity, which is known to have greater interobserver variability and to overestimate percentage DS compared with quantitative coronary angiograph (QCA). 82 Interestingly, a post hoc analysis of the ACUITY trial using QCA illustrated that even when DS≥30% was used to define a significant lesion, IR was independently associated with an increased risk of MACE (HR 1.36, 95% CI 1.11-1.68), although the risk increased with increasing DS thresholds (for DS threshold of ≥70%, HR 1.59, 95% CI 1.30-1.93). Score-based definitions of IR, such as the residual SYNTAX score, overcome some of the limitations around differences in anatomical definitions of lesion significance used across studies, allowing comparisons to be made more easily. In the current analysis we report a similar prognostic impact of IR irrespective of whether this is defined by anatomical or score-based definitions. Third, contemporary studies have shown that the functional significance of lesions on the basis of fractional flow reserve is a more important determinant of future cardiac events than anatomical/angiographic appearances. 18, [83] [84] [85] Operators may choose not to revascularize lesions due to their functional nonsignificance or location within vessels supplying infarcted and nonviable myocardium. A recent post hoc analysis of the FAME study 18 demonstrated that IR (as defined by residual SYNTAX score and SYNTAX revascularization index) was not associated with adverse outcome in the setting of complete functional revascularization, supporting the hypothesis that functional CR is more important than anatomical CR. The remaining studies that report outcomes following IR included in this analysis (with the exception of the aforementioned study 18 ) do not differentiate between the anatomical and the functional significance of incompletely revascularized lesions. The differences in the prognostic impact of incomplete revascularization across the different studies analyzed in this meta-analysis may relate to the above limitations, mainly variability in the definition of what is considered to be a significant coronary lesion, the site of the lesion, whether the lesions that were not revascularized were in infarcted nonviable territories or were functionally significant, the sample size of the cohort studied, and whether this would be adequately powered to detect a statistically significant difference and the nature of the cohort studied. Finally, most of the studies included in this analysis are derived from registry data; hence, the decision not to undertake CR by the operator may reflect uncaptured comorbidity or general frailty of the patient and so act as a surrogate of poor health status of the patients that will contribute to the poorer outcomes reported. Although nearly all of the studies have adjusted for differences in baseline characteristics, there remains a possibility of unmeasured confounding.
In conclusion, our analysis of data derived from over 150 000 patients undergoing PCI suggests that fewer than half of all patients with multivessel coronary artery disease have CR following PCI. We observe that CR is associated with decreased incidence of mortality, myocardial infarction, and MACE, irrespective of whether an anatomical or a score-based definition of IR was used and that the magnitude of risk relates to degree of CR. The findings of our analysis have several practical implications for interventional cardiologists. Our reported associations between IR and adverse clinical outcomes suggest that in patients with MVD, consideration should be given to the degree of CR that can be achieved by PCI when discussing choice of revascularization modality within the heart team, in addition to consideration of lesion complexity, functional significance, patient characteristics, and syntax score in line with current international recommendations. 86 At the very least these data speak of the need for further carefully conducted randomized trials to address this question.
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